CTLA4 and B-cell non-Hodgkin lymphoma: CTLA-4 is expressed on regulatory T (Treg) cells and is believed to act as an immune checkpoint receptor, which contributes to the inhibition and exhaustion of T-cells, and has an additional role in promoting the proliferation and survival of B-cell lymphoma (Herrmann et al., 2017).